Galway University Hospital Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2009
NCT01160731
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Galway Clinic | University Hospital Galway, NUI Galway, Ireland

Active Ingredients

Drugs in Phase 3 Trials (1)

norepinephrine (levophed) (1 trial)

Drugs in Phase 1 Trials (3)

cisplatin (platinol) (1 trial)

etoposide (vepesid) (1 trial)

panobinostat (farydak) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Lung Neoplasms (Phase 1)

Small Cell Lung Carcinoma (Phase 1)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 4